Scholarlink

Background <p>Although prior studies have suggested an association between benign prostatic hyperplasia (BPH) and metabolic abnormalities, many were limited by small sample sizes. The study aimed to identify metabolic risk factors related to BPH.</p> Methods <p>Following rigorous screening, 8,566 men aged 40 years or older were enrolled in 2022 in the current research. All participants underwent prostate and liver ultrasonography.</p> Results <p>The mean age of the subjects was 54.20 ± 9.37 years, Among them, 3,595 (41.96%) were diagnosed with BPH and 5519 (64.42%) had fatty liver disease (FLD), while 1,254 (14.63%) had diabetes. Multivariate analysis revealed that four variables, namely, age, prostate special antigen (PSA), FLD, and diabetes were related to BPH. Specifically, each 1-year increase in age was associated with an 8% increase in BPH risk (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.07–1.09). Elevated PSA was associated with a 91% increase in BPH risk (OR, 1.91; 95% CI, 1.79–2.04). The presence of FLD was linked to a 21% increased risk (OR, 1.21; 95% CI, 1.08–1.36), and diabetes was correlated with a 22% increased risk (OR, 1.22; 95% CI, 1.06–1.40).</p> Conclusion <p>Advanced age, elevated PSA levels, and the presence of FLD and/or diabetes are associated with an increased risk of BPH.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fatty liver and diabetes are related to benign prostate hyperplasia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月16日

查看全文
  • Dongyang Yu,
  • Zhongyang Duan,
  • Yan Xie

摘要

Background

Although prior studies have suggested an association between benign prostatic hyperplasia (BPH) and metabolic abnormalities, many were limited by small sample sizes. The study aimed to identify metabolic risk factors related to BPH.

Methods

Following rigorous screening, 8,566 men aged 40 years or older were enrolled in 2022 in the current research. All participants underwent prostate and liver ultrasonography.

Results

The mean age of the subjects was 54.20 ± 9.37 years, Among them, 3,595 (41.96%) were diagnosed with BPH and 5519 (64.42%) had fatty liver disease (FLD), while 1,254 (14.63%) had diabetes. Multivariate analysis revealed that four variables, namely, age, prostate special antigen (PSA), FLD, and diabetes were related to BPH. Specifically, each 1-year increase in age was associated with an 8% increase in BPH risk (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.07–1.09). Elevated PSA was associated with a 91% increase in BPH risk (OR, 1.91; 95% CI, 1.79–2.04). The presence of FLD was linked to a 21% increased risk (OR, 1.21; 95% CI, 1.08–1.36), and diabetes was correlated with a 22% increased risk (OR, 1.22; 95% CI, 1.06–1.40).

Conclusion

Advanced age, elevated PSA levels, and the presence of FLD and/or diabetes are associated with an increased risk of BPH.